{
  "ticker": "VRTX",
  "year": 2024,
  "quarter": 4,
  "last_updated": "2025-04-19T09:10:58.394959",
  "count": 13,
  "transactions": [
    {
      "id": 168445,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-11-15",
      "transaction_shares": "15",
      "transaction_price": "478.56",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 199368,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-11-15",
      "transaction_shares": "15",
      "transaction_price": "478.56",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 232564,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP,  Chief Scientific Officer",
      "transaction_date": "2024-11-15",
      "transaction_shares": "15",
      "transaction_price": "478.56",
      "transaction_type": "S",
      "shares_after_transaction": "25813"
    },
    {
      "id": 168495,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-11-11",
      "transaction_shares": "3000",
      "transaction_price": "518.27",
      "transaction_type": "S",
      "shares_after_transaction": "44137"
    },
    {
      "id": 199418,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-11-11",
      "transaction_shares": "3000",
      "transaction_price": "518.27",
      "transaction_type": "S",
      "shares_after_transaction": "44137"
    },
    {
      "id": 232614,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "WAGNER CHARLES F JR",
      "reporting_owner_cik": "0001223348",
      "reporting_owner_position": "EVP & Chief Financial Officer",
      "transaction_date": "2024-11-11",
      "transaction_shares": "3000",
      "transaction_price": "518.27",
      "transaction_type": "S",
      "shares_after_transaction": "44137"
    },
    {
      "id": 168443,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-11-08",
      "transaction_shares": "15198",
      "transaction_price": "515",
      "transaction_type": "S",
      "shares_after_transaction": "75772"
    },
    {
      "id": 199366,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-11-08",
      "transaction_shares": "15198",
      "transaction_price": "515",
      "transaction_type": "S",
      "shares_after_transaction": "75772"
    },
    {
      "id": 232562,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2024-11-08",
      "transaction_shares": "15198",
      "transaction_price": "515",
      "transaction_type": "S",
      "shares_after_transaction": "75772"
    },
    {
      "id": 140125,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "630",
      "transaction_price": "466.84",
      "transaction_type": "F",
      "shares_after_transaction": "17650"
    },
    {
      "id": 168520,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "630",
      "transaction_price": "466.84",
      "transaction_type": "F",
      "shares_after_transaction": "17650"
    },
    {
      "id": 199443,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "630",
      "transaction_price": "466.84",
      "transaction_type": "F",
      "shares_after_transaction": "17650"
    },
    {
      "id": 232640,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "630",
      "transaction_price": "466.84",
      "transaction_type": "F",
      "shares_after_transaction": "17650"
    }
  ]
}